Ceylon Graphite Corp. (TSXV:CYL)

Canada · Delayed Price · Currency is CAD

0.0200

0.00 (0.00%)

Oct 16, 2024, 3:30 PM EDT

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Oct '24 Oct 16, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	4	5	11	28	30	6	Upgrade
Market Cap Growth	-51.75%	-51.75%	-61.86%	-6.94%	377.06%	-24.72%	Upgrade
Enterprise Value	6	8	12	30	30	8	Upgrade
Last Close Price	0.02	0.03	0.07	0.21	0.24	0.10	Upgrade
PB Ratio	37.76	52.36	20.68	202.62	14.06	26.91	Upgrade
P/TBV Ratio	37.76	52.36	20.68	202.62	14.06	26.91	Upgrade
Debt / Equity Ratio	24.45	24.45	4.15	14.62	0.90	8.88	Upgrade
Quick Ratio	0.05	0.05	0.07	0.02	0.59	0.02	Upgrade
Current Ratio	0.05	0.05	0.10	0.11	0.62	0.10	Upgrade
Return on Equity (ROE)	-466.71%	-466.71%	-1032.75%	-346.38%	-331.41%	-433.32%	Upgrade
Return on Assets (ROA)	-18.91%	-18.91%	-30.62%	-45.53%	-45.88%	-21.73%	Upgrade
Return on Capital (ROIC)	-34.86%	-34.86%	-54.95%	-69.97%	-69.19%	-35.86%	Upgrade
Earnings Yield	-38.60%	-27.84%	-31.65%	-14.09%	-13.08%	-35.48%	Upgrade
FCF Yield	-6.85%	-4.94%	-26.50%	-8.00%	-9.05%	-24.77%	Upgrade
Buyback Yield / Dilution	-7.83%	-7.83%	-16.66%	-7.41%	-102.04%	-9.83%	Upgrade

Updated Feb 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.